Internal Medicine · Bronx, NY
NPI
1700979911
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
Mmg - Grand Concourse, 2532 Grand Concourse
Bronx, NY, 10458
Phone (718) 960-1500
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
348 services
Medicare patients, 2024
147
Average age 72
Drug cost, 2024
$2.4M
17,782 prescriptions
Company payments, 2025
$6,298
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amir Ansari-Ezabadi was code 99214 (office e&m - established), 122 times for 74 patients. In total Amir Ansari-Ezabadi billed 348 services in 11 codes, and Medicare paid $31K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-09-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 122 | 74 | $78.11 | $9,529 |
| 99233 Hospital E&M - Subsequent | Facility | 106 | 54 | $112.76 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 52 | 37 | $14.20 | $739 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 28 | 28 | $159.53 | $4,467 |
| 99213 Office E&M - Established | Office | 16 | 15 | $74.22 | $1,187 |
| 99223 Hospital E&M - Initial | Facility | 13 | 12 | $165.92 | $2,157 |
By year: 2022 $35K for 528 services; 2023 $42K for 418 services; 2024 $31K for 348 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amir Ansari-Ezabadi prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,633 prescriptions and refills. In total Amir Ansari-Ezabadi wrote 17,782 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,633 | 4,455 | 485 | $22K |
| Metformin Hcl Generic | 699 | 1,910 | 192 | $28K |
| Metoprolol Succinate Generic | 634 | 1,512 | 167 | $11K |
| Amlodipine Besylate Generic | 618 | 1,657 | 182 | $3,440 |
| Losartan Potassium Generic | 564 | 1,441 | 168 | $5,320 |
| Jardiance Empagliflozin | 492 | 842 | 99 | $478K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 429 | 474 | 89 | $15K |
| Diclofenac Sodium Generic | 428 | 489 | 146 | $59K |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 396 | 1,077 | 112 | $13K |
| Omeprazole Generic | 379 | 792 | 117 | $4,393 |
| Gabapentin Generic | 359 | 709 | 114 | $3,085 |
| Ozempic Semaglutide | 358 | 419 | 58 | $345K |
| Rosuvastatin Calcium Generic | 353 | 909 | 103 | $4,722 |
| Alendronate Sodium Generic | 350 | 851 | 105 | $2,080 |
| Tamsulosin Hcl Generic | 319 | 869 | 102 | $5,350 |
Brand drugs: 3,136 claims; generic drugs: 14,159 claims; opioid claims: 77.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amir Ansari-Ezabadi $6,298 ($6,298 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $1,254.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 10 | $1,254 |
| Lilly USA, LLC LLY | 4 | $496 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $494 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $490 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $388 |
| Axsome Therapeutics, Inc. AXSM | 3 | $375 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $372 |
| Novo Nordisk Inc NVO | 3 | $358 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 2 | $300 |
| Janssen Pharmaceuticals, Inc JNJ | 2 | $300 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.